fomesafen has been researched along with 2019 Novel Coronavirus Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malm, L | 1 |
| Andersson, U; Brines, M; Chang, EH; Chavan, SS; George, SJ; Pavlov, VA; Silverman, HA; Thompson, DA; Tracey, KJ; Tsaava, T; Tynan, A; Yang, H | 1 |
| Chai, Y; Chui, CSL; Fortin, S; Howard, R; Jang, JW; Kern, DM; Lau, WCY; Lee, DY; Li, J; Lin, X; Liu, KY; Luo, H; Man, KKC; Park, RW; Reich, C; Torre, CO; Wong, ICK; Yin, C | 1 |
| Hunziker, L; Pavlicek-Bahlo, M | 1 |
| Kewalramani, D; Krishnakumar, A; Mahalingam, H; Manokaran, RK | 1 |
5 other study(ies) available for fomesafen and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Reduced ability to produce reflex-evoked neurogenic inflammation, a sign of decreased defense against COVID-19 infection?
Topics: Aged, 80 and over; COVID-19; Histamine; Humans; Male; Neurogenic Inflammation; Reflex; SARS-CoV-2; Skin; Skin Tests | 2022 |
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; COVID-19; Cytokine Release Syndrome; Famotidine; Histamine; Histamine H2 Antagonists; Lipopolysaccharides; Mice; Reflex; Vagus Nerve | 2022 |
Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic.
Topics: Aged; Antipsychotic Agents; Cohort Studies; COVID-19; Dementia; Female; Humans; Male; Medicare; Pandemics; Reflex; United States | 2023 |
[Cough from a cardiologic perspective].
Topics: Cardiology; Cough; COVID-19; Humans; Reflex; SARS-CoV-2 | 2021 |
Guillain-Barré Syndrome with Preserved Reflexes in a Child after COVID-19 Infection.
Topics: Child; COVID-19; Family; Guillain-Barre Syndrome; Humans; Reflex; SARS-CoV-2 | 2021 |